Want supernormal returns? Look at these 4 sectors

There is no supernormal upside in IT and pharma sectors, but IT can be the dark horse among the two, says Manish Gunwani.

Warren Buffett's firm buying big into drug stocks. Should you too?

While there are concerns as to whether pharma stocks are fully pricing in a Covid windfall, analysts suggest Indian pharma isn’t just a Cov...

Gland Pharma stock gets its mojo back as grey market premium soars again

Shares of Gland Pharma traded at a Rs 140-150 premium in the grey market, the unofficial market for trading in unlisted shares, on Tuesday....

The understated husband-and-wife 'dream team' behind Pfizer's coronavirus vaccine

Pfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The compan...

Gland Pharma's Rs 6,480 crore IPO kicks off: Should you subscribe?

The Shanghai Fosun Pharma-owned company raised a total of Rs 1,943.86 crore from 70 anchor investors.

ED directs Gland Pharma to transfer Ramalinga Raju family's 6 mn shares to escrow account

"There is no risk in terms of Ramalinga Raju's shares, because they invested in the company (Gland Pharma) in the late 90s. And then they o...

Ahead of Gland Pharma IPO, ED wants Raju family's 3.87% stake transferred to it

The development comes nearly a decade after ED ordered Gland Pharma management to attach 600,000 shares held by 10 companies belonging to R...

Rakesh Jhunjhunwala, LIC hiked stake in this pharma company in Q2

Total holdings of mutual fund houses in the company also increased to 12.58 per cent from 11.94 per cent on a quarter-on-quarter basis, dat...

Betting on pharma? Build a basket of these stocks

We have probably seen 20% of the rerating in pharma but it will take about one, one and a half years for the entire thing to play out, says...

Telangana opposes move to allocate pharma parks project based on costs

The Union government, which proposes to allocate Rs 1,000 crore for each of the three bulk drug parks that will be chosen based on competit...

Bullish on pharma? 4 big challenges ahead

Chinese manufacturers have increased the cost of key starting materials (KSMs), or intermediates, by up to 20%, escalating the input cost f...

China hikes prices of key drug ingredients

While increased prices will put cost pressure on the domestic industry over the next few months, more importantly it has sparked speculatio...

Pharma firms discover glamour in dowdy APIs

Pharma companies have posted smart growth in API sales for the quarter due to increased demand of certain APIs used in the Covid-19 treatme...

Centre looking to hike import duty on bulk drugs, in bid to boost local manufacturing

The department of pharmaceuticals (DoP) is mulling the proposal as it pushes to make India self-reliant on APIs. A committee of experts for...

Sigh of relief for pharmaceutical industry: India’s pain eases as China resumes bulk drug supplies

Resumption of normal supplies has also calmed worries, at least for now, about the Sino-Indian border standoff affecting imports from China...

74% Chinese-owned Hyderabad pharma firm files for IPO

The fresh issue and the offer for sale together is expected to take the IPO size to around Rs 3,000 crore.

Chinese firm-backed Gland Pharma files for IPO; may raise up to Rs 6,000 crore

The company may raise up to $800 million or Rs 6,000 crore, a source with the knowledge of the matter said.